{"nctId":"NCT00163189","briefTitle":"Evolution Of Growth Rate In Children With Growth Retardation Due to Glucocorticosteroid Therapy And Treated By Genotonorm","startDateStruct":{"date":"2005-01"},"conditions":["Growth Hormone Deficiency"],"count":98,"armGroups":[{"label":"Somatropin","type":"EXPERIMENTAL","interventionNames":["Drug: Somatropin"]}],"interventions":[{"name":"Somatropin","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Glucocorticosteroid treatment for 12 months at least\n* Bone age \\< 15 years for a boy and \\< 13 years for a girl\n* Child measured height \\< - 2 SD, Child currently treated by GH\n\nExclusion Criteria:\n\n* Known diabetes (type 1 or type 2)\n* A previous history of intolerance or hypersensitivity to the study drug or to drugs with similar chemical structures","healthyVolunteers":false,"sex":"ALL","stdAges":["CHILD","ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Change From Baseline in Height Standard Deviation Score (SDS) for Chronological Age (CA) at Month 36: Full Analysis Population","description":"Height was measured using a wall mounted device (example, Harpenden stadiometer). The standing height of the participant was measured two times and the mean of these measurements was recorded. Height SDS CA Yx = (height Yx - reference mean for CA Yx) / reference SD for CA Yx; Yx refers to the value at particular timepoint x. Height in SDS was calculated using Sempe reference means and SD for height. CA calculated as integer (Date of height measurement-Date of birth)/365.25\\*12.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-2.91","spread":"1.19"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.80","spread":"1.03"}]}]}]},{"type":"PRIMARY","title":"Change From Baseline in Height Standard Deviation Score (SD) for Chronological Age (CA) at Month 36: Per Protocol (PP) Population","description":"Height was measured using a wall mounted device (example, Harpenden stadiometer). The standing height of the participant was measured two times and the mean of these measurements was recorded. Height SDS CA Yx = (height Yx - reference mean for CA Yx) / reference SD for CA Yx; Yx refers to the value at particular timepoint x. Height in SDS was calculated using Sempe reference means and SD for height. CA calculated as integer (Date of height measurement-Date of birth)/365.25\\*12.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-2.86","spread":"0.89"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.81","spread":"1.18"}]}]}]},{"type":"SECONDARY","title":"Mean Height","description":"The standing height measurements were performed using a wall mounted device (example Harpenden Stadiometer). The standing height of the participant was measured two times and the mean of these measurements was recorded.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"133.9","spread":"15.7"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"139.5","spread":"16.8"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"146.0","spread":"16.4"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"150.4","spread":"16.0"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"152.4","spread":"16.0"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"156.0","spread":"11.3"}]}]}]},{"type":"SECONDARY","title":"Mean Height Standard Deviation Score (SDS) for Bone Age (BA)","description":"The standing height measurements were performed using a wall mounted device (example Harpenden Stadiometer). The standing height of the participant was measured two times and the mean of these measurements was recorded. Height SDS BA Yx = (height Yx - reference mean for BA Yx) / reference SD for BA Yx; Yx refers to the value at particular timepoint x. Height in SDS was calculated using Sempe reference means and SD for height. BA was estimated locally using an X-ray from the left wrist and hand.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.29","spread":"1.15"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.36","spread":"1.52"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.11","spread":"1.36"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.14","spread":"1.48"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.26","spread":"1.28"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.19","spread":"1.15"}]}]}]},{"type":"SECONDARY","title":"Annual Growth Rate (AGR)","description":"AGR at Yx was derived by subtracting AGR at baseline from Yx value. AGR was calculated each year and re scaled to 1 year if the interval between Yx and Y\\[x-1\\] was not 365 days, as long as a participant remained in the study. AGR at Yx was calculated using the previous height measurements (Y\\[x-1\\]) and height recorded at Yx (AGR Yx = \\[height Yx-height Y{x-1}\\] / (\\[date of Yx - date of Y{x-1}\\] /365.25). Yx refers to the value at particular timepoint x.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3.0","spread":"2.0"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.7","spread":"2.6"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.0","spread":"2.7"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.9","spread":"2.7"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.8","spread":"2.5"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.9","spread":"3.0"}]}]}]},{"type":"SECONDARY","title":"Growth Rate (GR) Standard Deviation Score (SDS) for Bone Age (BA)","description":"GR SDS BA Yx = (GR Yx - reference mean for BA Yx) / reference SD for BA Yx; Yx refers to the value at particular timepoint x. GR in SDS was calculated using Sempe reference means and SD for GR. BA was estimated locally using an X-ray from the left wrist and hand.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.13","spread":"2.15"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.07","spread":"2.51"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.05","spread":"1.94"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.00","spread":"1.38"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.43","spread":"1.22"}]}]}]},{"type":"SECONDARY","title":"Growth Rate (GR) Standard Deviation Score (SDS) for Chronological Age (CA)","description":"GR SDS CA Yx = (GR Yx - reference mean for CA Yx) / reference SD for CA Yx; Yx refers to the value at particular timepoint x. GR in SDS was calculated using Sempe reference means and SD for GR. CA calculated as integer (Date of height measurement-Date of birth)/365.25\\*12.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-2.04","spread":"2.03"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.77","spread":"4.29"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.26","spread":"16.79"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.64","spread":"9.06"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.93","spread":"2.73"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.40","spread":"1.71"}]}]}]},{"type":"SECONDARY","title":"Body Mass Index (BMI)","description":"BMI was calculated by weight divided by height squared and measured as kilogram per square meter (kg/m\\^2).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"19.4","spread":"3.6"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"19.1","spread":"3.1"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"19.4","spread":"3.0"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"19.4","spread":"2.4"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"19.7","spread":"3.0"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"20.8","spread":"3.3"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Height at Month 12, 24, 36, 48 and 60","description":"The standing height measurements were performed using a wall mounted device (example Harpenden Stadiometer). The standing height of the participant was measured two times and the mean of these measurements was recorded.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"133.9","spread":"15.7"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.8","spread":"2.8"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"12.9","spread":"4.7"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"18.8","spread":"6.1"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"23.9","spread":"8.5"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"30.3","spread":"7.6"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Height Standard Deviation Score (SDS) for Chronological Age (CA) at Month 12, 24, 48 and 60","description":"The standing height measurements were performed using a wall mounted device (example Harpenden Stadiometer). The standing height of the participant was measured two times and the mean of these measurements was recorded. Height SDS CA Yx = (height Yx - reference mean for CA Yx) / reference SD for CA Yx; Yx refers to the value at particular timepoint x. Height in SDS was calculated using Sempe reference means and SD for height. CA calculated as integer (Date of height measurement-Date of birth)/365.25\\*12.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-2.91","spread":"1.19"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.28","spread":"0.57"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.57","spread":"0.95"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.82","spread":"1.42"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.75","spread":"1.13"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Height Standard Deviation Score (SDS) for Bone Age (BA) at Month 12, 24, 36, 48 and 60","description":"The standing height measurements were performed using a wall mounted device (example Harpenden Stadiometer). The standing height of the participant was measured two times and the mean of these measurements was recorded. Height SDS BA Yx = (height Yx - reference mean for BA Yx) / reference SD for BA Yx; Yx refers to the value at particular timepoint x. Height in SDS was calculated using Sempe reference means and SD for height. BA was estimated locally using an X-ray from the left wrist and hand.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.29","spread":"1.15"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.02","spread":"0.99"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.28","spread":"1.18"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.31","spread":"1.17"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.08","spread":"1.30"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.01","spread":"1.33"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Bone Age (BA) at Month 12, 24, 36, 48 and 60","description":"BA was estimated locally using an X-ray from the left wrist and hand.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"117.9","spread":"34.6"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"17.8","spread":"11.0"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"28.2","spread":"17.9"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"36.5","spread":"17.8"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"52.8","spread":"21.2"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"70.0","spread":"27.0"}]}]}]},{"type":"SECONDARY","title":"Ratio of Bone Age (BA) to Chronological Age (CA)","description":"BA was estimated locally using an X-ray from the left wrist and hand. CA at the date of corresponding X-ray (Date of X-ray - Date of birth)/365.25. Ratio of BA/CA at each annual study visit was calculated.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.78","spread":"0.10"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.82","spread":"0.11"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.80","spread":"0.09"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.79","spread":"0.10"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.81","spread":"0.08"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.85","spread":"0.10"}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Number of Participants With Treatment-Emergent Adverse Events (AEs) or Serious Adverse Events (SAEs)","description":"An AE was any untoward medical occurrence in a participant who received study drug without regard to possibility of causal relationship. An SAE was an AE resulting in any of the following outcomes or deemed significant for any other reason: death; initial or prolonged inpatient hospitalization; life-threatening experience (immediate risk of dying); persistent or significant disability/incapacity; congenital anomaly. Treatment-emergent are events between first dose of study drug and up to 28 days after last dose that were absent before treatment or that worsened relative to pretreatment state. AEs include both SAEs and non-SAEs.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"84","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"45","spread":null}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Number of Participants With Significant Changes in Physical Examinations","description":"Number of participants with clinically significant physical examinations changes since previous visit were reported. Physical examination including estimation of pubertal stage and blood pressure measurement;","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"16","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"16","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"11","spread":null}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Number of Participants With at Least 1 Medical or Surgical History","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"67","spread":null}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Number of Participants Who Received Concomitant Medications","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"98","spread":null}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Fasting Serum Insulin Like Growth Factor-1 (IGF-1) Levels","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"335","spread":"157"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"604","spread":"291"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"538","spread":"268"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"624","spread":"251"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"579","spread":"262"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"559","spread":"250"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"511","spread":"186"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"555","spread":"224"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"581","spread":"244"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"593","spread":"184"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"501","spread":"180"}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Fasting and Postprandial Plasma Glucose Levels at Month 12, 24, 36, 48 and 60","description":"Fasting and 2 hours plasma glucose levels were assessed using standard oral glucose tolerance test (OGTT).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4.5","spread":"0.7"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.6","spread":"0.7"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.7","spread":"0.6"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.6","spread":"0.5"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.7","spread":"0.4"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.5","spread":"0.6"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.6","spread":"1.2"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.1","spread":"1.4"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.1","spread":"1.4"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.4","spread":"1.6"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.1","spread":"1.1"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.3","spread":"1.5"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":45,"n":98},"commonTop":["Insulin-like growth factor increased","Nephrotic syndrome","Diarrhoea","Arthralgia","Bronchitis"]}}}